Literature DB >> 9742082

The nuclear orphan receptor CAR-retinoid X receptor heterodimer activates the phenobarbital-responsive enhancer module of the CYP2B gene.

P Honkakoski1, I Zelko, T Sueyoshi, M Negishi.   

Abstract

PBREM, the phenobarbital-responsive enhancer module of the cytochrome P-450 Cyp2b10 gene, contains two potential nuclear receptor binding sites, NR1 and NR2. Consistent with the finding that anti-retinoid X receptor (RXR) could supershift the NR1-nuclear protein complex, DNA affinity chromatography with NR1 oligonucleotides enriched the nuclear orphan receptor RXR from the hepatic nuclear extracts of phenobarbital-treated mice. In addition to RXR, the nuclear orphan receptor CAR was present in the same enriched fraction. In the phenobarbital-treated mice, the binding of both CAR and RXR was rapidly increased before the induction of CYP2B10 mRNA. In vitro-translated CAR bound to NR1, but only in the presence of similarly prepared RXR. PBREM was synergistically activated by transfection of CAR and RXR in HepG2 and HEK293 cells when the NR1 site was functional. A CAR-RXR heterodimer has thus been characterized as a trans-acting factor for the phenobarbital-inducible Cyp2b10 gene.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9742082      PMCID: PMC109151          DOI: 10.1128/MCB.18.10.5652

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  26 in total

1.  An orphan nuclear hormone receptor that lacks a DNA binding domain and heterodimerizes with other receptors.

Authors:  W Seol; H S Choi; D D Moore
Journal:  Science       Date:  1996-05-31       Impact factor: 47.728

2.  Differential transactivation by two isoforms of the orphan nuclear hormone receptor CAR.

Authors:  H S Choi; M Chung; I Tzameli; D Simha; Y K Lee; W Seol; D D Moore
Journal:  J Biol Chem       Date:  1997-09-19       Impact factor: 5.157

3.  Characterization of phenobarbital-inducible mouse Cyp2b10 gene transcription in primary hepatocytes.

Authors:  P Honkakoski; R Moore; J Gynther; M Negishi
Journal:  J Biol Chem       Date:  1996-04-19       Impact factor: 5.157

Review 4.  Xenobiotic-inducible transcription of cytochrome P450 genes.

Authors:  M S Denison; J P Whitlock
Journal:  J Biol Chem       Date:  1995-08-04       Impact factor: 5.157

5.  A DNA methylation site in the male-specific P450 (Cyp 2d-9) promoter and binding of the heteromeric transcription factor GABP.

Authors:  N Yokomori; R Kobayashi; R Moore; T Sueyoshi; M Negishi
Journal:  Mol Cell Biol       Date:  1995-10       Impact factor: 4.272

Review 6.  The RXR heterodimers and orphan receptors.

Authors:  D J Mangelsdorf; R M Evans
Journal:  Cell       Date:  1995-12-15       Impact factor: 41.582

7.  Characterization of a phenobarbital-responsive enhancer module in mouse P450 Cyp2b10 gene.

Authors:  P Honkakoski; M Negishi
Journal:  J Biol Chem       Date:  1997-06-06       Impact factor: 5.157

8.  The orphan nuclear receptor LXRalpha is positively and negatively regulated by distinct products of mevalonate metabolism.

Authors:  B M Forman; B Ruan; J Chen; G J Schroepfer; R M Evans
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-30       Impact factor: 11.205

Review 9.  Role of the peroxisome proliferator-activated receptor in cytochrome P450 4A gene regulation.

Authors:  E F Johnson; C N Palmer; K J Griffin; M H Hsu
Journal:  FASEB J       Date:  1996-09       Impact factor: 5.191

10.  Phenobarbital induction mediated by a distal CYP2B2 sequence in rat liver transiently transfected in situ.

Authors:  Y Park; H Li; B Kemper
Journal:  J Biol Chem       Date:  1996-09-27       Impact factor: 5.157

View more
  194 in total

1.  Functional interactions between an atypical NF-kappaB site from the rat CYP2B1 promoter and the transcriptional repressor RBP-Jkappa/CBF1.

Authors:  S H Lee; X Wang; J DeJong
Journal:  Nucleic Acids Res       Date:  2000-05-15       Impact factor: 16.971

2.  A novel drug-regulated gene expression system based on the nuclear receptor constitutive androstane receptor (CAR).

Authors:  P Honkakoski; I Jääskeläinen; M Kortelahti; A Urtti
Journal:  Pharm Res       Date:  2001-02       Impact factor: 4.200

3.  Phosphorylated Nuclear Receptor CAR Forms a Homodimer To Repress Its Constitutive Activity for Ligand Activation.

Authors:  Ryota Shizu; Makoto Osabe; Lalith Perera; Rick Moore; Tatsuya Sueyoshi; Masahiko Negishi
Journal:  Mol Cell Biol       Date:  2017-05-02       Impact factor: 4.272

Review 4.  Cytochrome P450 3A and their regulation.

Authors:  Oliver Burk; Leszek Wojnowski
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-10-21       Impact factor: 3.000

Review 5.  A ligand-based approach to understanding selectivity of nuclear hormone receptors PXR, CAR, FXR, LXRalpha, and LXRbeta.

Authors:  Sean Ekins; Leonid Mirny; Erin G Schuetz
Journal:  Pharm Res       Date:  2002-12       Impact factor: 4.200

Review 6.  Orphan nuclear receptors as targets for drug development.

Authors:  Subhajit Mukherjee; Sridhar Mani
Journal:  Pharm Res       Date:  2010-04-06       Impact factor: 4.200

7.  Multiple genes exhibit phenobarbital-induced constitutive active/androstane receptor-mediated DNA methylation changes during liver tumorigenesis and in liver tumors.

Authors:  Jennifer M Phillips; Jay I Goodman
Journal:  Toxicol Sci       Date:  2009-02-20       Impact factor: 4.849

8.  Control of steroid, heme, and carcinogen metabolism by nuclear pregnane X receptor and constitutive androstane receptor.

Authors:  Wen Xie; Mei-Fei Yeuh; Anna Radominska-Pandya; Simrat P S Saini; Yoichi Negishi; Bobbie Sue Bottroff; Geraldine Y Cabrera; Robert H Tukey; Ronald M Evans
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-18       Impact factor: 11.205

Review 9.  The Roles of Xenobiotic Receptors: Beyond Chemical Disposition.

Authors:  Bryan Mackowiak; Jessica Hodge; Sydney Stern; Hongbing Wang
Journal:  Drug Metab Dispos       Date:  2018-05-14       Impact factor: 3.922

10.  Flame retardant BDE-47 effectively activates nuclear receptor CAR in human primary hepatocytes.

Authors:  Tatsuya Sueyoshi; Linhao Li; Hongbing Wang; Rick Moore; Prasada Rao S Kodavanti; Hans-Joachim Lehmler; Masahiko Negishi; Linda S Birnbaum
Journal:  Toxicol Sci       Date:  2013-11-11       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.